Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|October 26, 2006
Functional inactivation of P53 as a potential mechanism of MLL leukemogenesisDmitri Wiederschain, Zhi-min Yuan
Current Opinion in Oncology|November 29, 2007
Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and developmentSusan Wee, Christoph Lengauer, Dmitri Wiederschain
Molecular and Cellular Biology|July 2, 2003
Critical contribution of the MDM2 acidic domain to p53 ubiquitinationHidehiko Kawai, Dmitri Wiederschain, Zhi-Min Yuan
The Journal of Biological Chemistry|April 27, 2005
Multiple mixed lineage leukemia (MLL) fusion proteins suppress p53-mediated response to DNA damageDmitri Wiederschain, Hidehiko Kawai, Ali Shilatifard, et al.
Molecular and Cellular Biology|May 30, 2003
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELLDmitri Wiederschain, Hidehiko Kawai, JiJie Gu, et al.
Cancer Research|July 10, 2007
RING domain-mediated interaction is a requirement for MDM2's E3 ligase activityHidehiko Kawai, Vanessa Lopez-Pajares, Mihee M Kim, et al.
The Journal of Biological Chemistry|September 10, 2003
DNA damage-induced MDMX degradation is mediated by MDM2Hidehiko Kawai, Dmitri Wiederschain, Hiroyuki Kitao, et al.
Clinical Immunology (Orlando, Fla.)|April 15, 2024
ICOS agonist vopratelimab modulates follicular helper T cells and improves B cell function in common variable immunodeficiencyAli Sepahi, Hsi-En Ho, Prapti Vyas, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
PTEN-deficient cancers depend on PIK3CBSusan Wee, Dmitri Wiederschain, Sauveur-Michel Maira, et al.
The Journal of Biological Chemistry|April 16, 2002
Mutual dependence of MDM2 and MDMX in their functional inactivation of p53Jijie Gu, Hidehiko Kawai, Linghu Nie, et al.
Pageof 4